https://www.myemnotes.com/ 2026-04-11T00:09:39+00:00 https://www.myemnotes.com/ https://www.myemnotes.com/lib/exe/fetch.php?media=logo.png text/html 2023-04-25T12:16:10+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.myemnotes.com/doku.php?id=wiki:haematology:anticoagulants&rev=1682424970&do=diff Coagulation Parenteral Anticoagulants Heparin * (unfractionated) initiates anticoagulation rapidly but has a short duration of action * can be used in those at high risk of bleeding because its effect can be terminated rapidly by stopping the infusion. text/html 2023-04-25T12:16:10+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.myemnotes.com/doku.php?id=wiki:haematology:dic&rev=1682424970&do=diff DIC Disseminated Intravascular Coagulation ---------- References include: DIC review 2014 dDimer review in labs, applications 2018 text/html 2023-04-27T19:39:34+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.myemnotes.com/doku.php?id=wiki:haematology:sicklecell&rev=1682624374&do=diff Sickle Cell * Sickle cell disease (SCD) and its variants - genetic disorders resulting from the presence of a mutated form of Hb, HbS. * most common form of SCD = homozygous HbS disease (HbSS), an autosomal recessive disorder Pre-empting factors which may promote erythrocyte sickling (and vaso-occlusive crises) include: